PATENT CLAIM ANALYSIS

Application Number: 15887753
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "662000"]

Abstract:
The invention provides extended release amantadine compositions for once daily administration of amantadine to a subject.

Claim (Index 3):
The pharmaceutical composition of  claim 1 , wherein the sustained release coating is erodible under conditions prevailing in the gastrointestinal tract.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.0625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12757819', '12512701', '13284630', '13536525', '13536008']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8807804965414734
- 35 USC 102 Novelty (BERT): 0.5543811909175738
- Combined Prediction Score: 0.8481405659790834
- Mean Citation Score: 589.6318679999998
- Max Citation Score: 594.49335
- Similarity Product: 290.7288942752972

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test